Final Evidence Report and Meeting Summary
New England CEPAC

PDF cover

Hemophilia A: Final Evidence Report

ICER’s final report reviewing the clinical effectiveness and value of emicizumab for patients with hemophilia A and inhibitors to factor VIII.


View All Materials on this Topic or Go Back to View More Materials